iRhythm Technologies, Inc.

iRhythm Technologies is a medical device company specializing in ambulatory cardiac monitoring through its Zio platform. The company provides an end-to-end cardiac monitoring service that includes wearable ECG monitors, FDA-cleared AI-powered analysis, and comprehensive reporting verified by Certified Cardiographic Technicians. iRhythm has analyzed data from over 10 million patients and accumulated more than 2 billion hours of curated heartbeat data.

The company's Zio ECG monitors are designed for extended wear periods, achieving near-perfect patient compliance rates while delivering continuous, uninterrupted cardiac monitoring. The platform includes ZioSuite for provider management, EHR integration capabilities, the MyZio patient app for symptom logging, and comprehensive reports generated through deep-learned algorithms that demonstrate 99% physician agreement. The service targets cardiology and electrophysiology practices as well as primary care providers.

Clinical studies including the AVALON and CAMELOT trials have demonstrated the platform's effectiveness in arrhythmia diagnosis, with published research showing associations with high diagnostic yield and reduced retesting compared to other monitoring services. The company's AI algorithm has received FDA 510K clearance and regulatory approval in the European Union, United Kingdom, Switzerland, and Japan.

Choose iRhythm if you need a turnkey cardiac monitoring solution with strong clinical evidence for improved diagnostic outcomes and reduced retesting. The platform excels in scenarios where patient compliance is critical and where practices want to outsource the entire monitoring workflow rather than manage it internally.

Expect a managed service engagement where iRhythm provides devices, handles all data analysis through AI and certified technicians, and delivers verified reports through an integrated portal. The company's extensive patient database and regulatory clearances make it suitable for practices seeking clinically validated, compliant cardiac monitoring at scale.

iRhythm is exclusively focused on healthcare, specifically cardiac care delivery for cardiology, electrophysiology, and primary care settings. The company's entire business model centers on improving arrhythmia diagnosis through wearable cardiac monitoring technology and clinical decision support.

The platform addresses healthcare-specific regulatory requirements with FDA 510K clearance, CE mark, and other international medical device approvals. Clinical evidence from multiple peer-reviewed studies demonstrates the service's impact on diagnostic yield, healthcare resource utilization, and patient outcomes in Medicare and commercially insured populations.

Mid-to-large cardiology practices, hospital-based electrophysiology departments, and integrated health systems seeking to improve arrhythmia detection without building internal monitoring infrastructure. Organizations that value clinical evidence, regulatory compliance, and patient-centered design. Practices managing high volumes of patients requiring extended cardiac monitoring where patient compliance and diagnostic accuracy are primary concerns.